NEW YORK — JP Morgan and Piper Sandler on Monday initiated coverage of Ortho Clinical Diagnostics with Overweight ratings. JP Morgan initiated coverage with a share price target of $25, while Piper Sandler initiated coverage at $27.
Further, Evercore ISI initiated coverage at $26 with an Outperform rating, and UBS initiated coverage at $23 with a Buy rating.